𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Emerging therapies in type 2 diabetes

✍ Scribed by Barnett, Anthony

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
163 KB
Volume
18
Category
Article
ISSN
1357-8170

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Nicotine in psychiatry: pathology and em
Nicotine in psychiatry: pathology and emerging therapies
✍ A. Parrott πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 35 KB

Chapters follow on ICH, CRF design, data capture, planning, data validation, QA, performance metrics, data presentation, data coding including MedDRA (an ICH standard), database design for central laboratories, computer systems, software validation, reengineering the CDM process, working with CROs,

Type 2 diabetesβ€”Therapy with dipeptidyl
Type 2 diabetesβ€”Therapy with dipeptidyl peptidase IV inhibitors
✍ Hans-Ulrich Demuth; Christopher H.S. McIntosh; Raymond A. Pederson πŸ“‚ Article πŸ“… 2005 πŸ› Elsevier Science 🌐 English βš– 803 KB

The sole application of an inhibitor of the dipeptidyl peptidase DP IV (also DP 4, CD26, DPP-IV or DPP-4) to a mammal subsequently leading to improved glucose tolerance marks a major breakthrough in metabolic research bearing the potential of a new revolutionary diabetes therapy. This was demonstrat